메뉴 건너뛰기




Volumn 11, Issue 19, 2003, Pages 4235-4244

3-D-QSAR CoMFA and CoMSIA studies on tetrahydrofuroyl-L-phenylalanine derivatives as VLA-4 antagonists

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; PHENYLALANINE DERIVATIVE; TETRAHYDROFUROYLPHENYLALANINE; UNCLASSIFIED DRUG;

EID: 0042389544     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(03)00408-5     Document Type: Article
Times cited : (11)

References (28)
  • 3
    • 0029091551 scopus 로고
    • (a) Abraham W.M., Sielczak M.W., Ahmed A., Cortes A., Lauredo I.T., Kim J., Pepinsky B., Benjamin C.D., Leone D.R., Lobb R.R., Weller P.F. J. Clin. Invest. 93:1994;776 (b) Milne A.A.Y., Piper P.J. Eur. J. Pharmacol. 282:1995;243.
    • (1995) Eur. J. Pharmacol. , vol.282 , pp. 243
    • Milne, A.A.Y.1    Piper, P.J.2
  • 4
    • 0026506799 scopus 로고
    • (a) Yednock T.A., Cannon D., Fritz L.C. Nature. 356:1992;63 (b) Kesztheylyi E., Karlik S., Hyduk S., Rice A., Gordon G., Yednock T., Horner H. Neurology. 47:1996;1053.
    • (1992) Nature , vol.356 , pp. 63
    • Yednock, T.A.1    Cannon, D.2    Fritz, L.C.3
  • 8
    • 85031075157 scopus 로고    scopus 로고
    • Natalizumab, Biogen, Inc, Press Release 2002, April 29, Reference number RF449588.
    • Natalizumab, Biogen, Inc, Press Release 2002, April 29, Reference number RF449588.
  • 9
    • 85031071026 scopus 로고    scopus 로고
    • SB-683698, GlaxoSmithKline plc, Company Brochure 2001, February 22, Reference number RF399771.
    • (a) SB-683698, GlaxoSmithKline plc, Company Brochure 2001, February 22, Reference number RF399771. (b) GW-559090, GlaxoSmithKline plc, Company Publication 2001, October 23, Reference number RF426830. (c) IVL-745 and IVL-1031, Aventis Pharma AG, Company Presentation 2001, May 15, Reference number RF409257. (d) R-411, Hoffmann-La Roche Inc, Company Presentation 2002, April 16, Reference number RF448015.
  • 10
    • 85031076092 scopus 로고    scopus 로고
    • GW-559090, GlaxoSmithKline plc, Company Publication 2001, October 23, Reference number RF426830.
    • (a) SB-683698, GlaxoSmithKline plc, Company Brochure 2001, February 22, Reference number RF399771. (b) GW-559090, GlaxoSmithKline plc, Company Publication 2001, October 23, Reference number RF426830. (c) IVL-745 and IVL-1031, Aventis Pharma AG, Company Presentation 2001, May 15, Reference number RF409257. (d) R-411, Hoffmann-La Roche Inc, Company Presentation 2002, April 16, Reference number RF448015.
  • 11
    • 85031068446 scopus 로고    scopus 로고
    • IVL-745 and IVL-1031, Aventis Pharma AG, Company Presentation 2001, May 15, Reference number RF409257.
    • (a) SB-683698, GlaxoSmithKline plc, Company Brochure 2001, February 22, Reference number RF399771. (b) GW-559090, GlaxoSmithKline plc, Company Publication 2001, October 23, Reference number RF426830. (c) IVL-745 and IVL-1031, Aventis Pharma AG, Company Presentation 2001, May 15, Reference number RF409257. (d) R-411, Hoffmann-La Roche Inc, Company Presentation 2002, April 16, Reference number RF448015.
  • 12
    • 85031075255 scopus 로고    scopus 로고
    • R-411, Hoffmann-La Roche Inc, Company Presentation 2002, April 16, Reference number RF448015.
    • (a) SB-683698, GlaxoSmithKline plc, Company Brochure 2001, February 22, Reference number RF399771. (b) GW-559090, GlaxoSmithKline plc, Company Publication 2001, October 23, Reference number RF426830. (c) IVL-745 and IVL-1031, Aventis Pharma AG, Company Presentation 2001, May 15, Reference number RF409257. (d) R-411, Hoffmann-La Roche Inc, Company Presentation 2002, April 16, Reference number RF448015.
  • 13
    • 85031083223 scopus 로고    scopus 로고
    • Boston, Aug 20-24, 2000; American Chemical Society: Washington, DC, 2000; MEDI 140.
    • (a) Chen, Q.; Li, j.; Maxwell, D.; Holland, G.; Dixon, R.; You, T. 220th National Meeting of the American Chemical Society, Boston, Aug 20-24, 2000; American Chemical Society: Washington, DC, 2000; MEDI 140. (b) Singh, J.; Zheng, Z.; Sprague, P.; Van Vilhemen, H.; Castro, A.C.; Adams, S.P. WO 9804913. (c) Singh J., Vlijmen H.V., Liao Y., Lee W., Mark C., Harris M., Shu I., Gill A., Cuervo J., Abraham W.M., Adams S. P. J. Med. Chem. 45:2002;2988.
    • 220th National Meeting of the American Chemical Society
    • Chen, Q.1    Li, J.2    Maxwell, D.3    Holland, G.4    Dixon, R.5    You, T.6
  • 14
    • 85031067107 scopus 로고    scopus 로고
    • S.P. WO 9804913.
    • (a) Chen, Q.; Li, j.; Maxwell, D.; Holland, G.; Dixon, R.; You, T. 220th National Meeting of the American Chemical Society, Boston, Aug 20-24, 2000; American Chemical Society: Washington, DC, 2000; MEDI 140. (b) Singh, J.; Zheng, Z.; Sprague, P.; Van Vilhemen, H.; Castro, A.C.; Adams, S.P. WO 9804913. (c) Singh J., Vlijmen H.V., Liao Y., Lee W., Mark C., Harris M., Shu I., Gill A., Cuervo J., Abraham W.M., Adams S. P. J. Med. Chem. 45:2002;2988.
    • Singh, J.1    Zheng, Z.2    Sprague, P.3    Van Vilhemen, H.4    Castro, A.C.5    Adams6
  • 15
    • 0037019269 scopus 로고    scopus 로고
    • (a) Chen, Q.; Li, j.; Maxwell, D.; Holland, G.; Dixon, R.; You, T. 220th National Meeting of the American Chemical Society, Boston, Aug 20-24, 2000; American Chemical Society: Washington, DC, 2000; MEDI 140. (b) Singh, J.; Zheng, Z.; Sprague, P.; Van Vilhemen, H.; Castro, A.C.; Adams, S.P. WO 9804913. (c) Singh J., Vlijmen H.V., Liao Y., Lee W., Mark C., Harris M., Shu I., Gill A., Cuervo J., Abraham W.M., Adams S. P. J. Med. Chem. 45:2002;2988.
    • (2002) P. J. Med. Chem. , vol.45 , pp. 2988
    • Singh, J.1    Vlijmen, H.V.2    Liao, Y.3    Lee, W.4    Mark, C.5    Harris, M.6    Shu, I.7    Gill, A.8    Cuervo, J.9    Abraham, W.M.10    Adams, S.11
  • 20
    • 85031081070 scopus 로고    scopus 로고
    • SYBYL 6.8, Tripos Inc.: 1669, S. Hanley Road, Suite 303, St. Louis, MO 63144-2913, USA.
    • SYBYL 6.8, Tripos Inc.: 1669, S. Hanley Road, Suite 303, St. Louis, MO 63144-2913, USA.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.